Immediate Impact

1 from Science/Nature 26 standout
Sub-graph 1 of 13

Citing Papers

Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
2025 Standout
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
1 intermediate paper

Works of Hideyasu Yamada being referenced

Effects of Lung Function-Related Genes and TSLP on COPD Phenotypes
2020

Author Peers

Author Last Decade Papers Cites
Hideyasu Yamada 150 110 18 57 28 215
Hiromi Tadaki 86 103 8 36 25 255
Tadahisa Numakura 96 110 9 65 27 296
Shaw‐Woei Leu 71 108 14 71 20 266
Morihiro Okazaki 98 75 15 35 29 217
Yasuko Fuchimoto 95 154 50 55 25 258
Jared Silver 201 90 4 29 31 269
Andrzej Obojski 93 64 7 77 26 252
Xiaoping Lai 70 22 18 33 28 267
Chuntao Liu 126 120 9 16 29 189
Hiroshi Kitazawa 36 45 6 50 23 148

All Works

Loading papers...

Rankless by CCL
2026